Literature DB >> 30099915

Immunobiology of periprosthetic inflammation and pain following ultra-high-molecular-weight-polyethylene wear debris in the lumbar spine.

John H Werner1, John H Rosenberg1, Kristen L Keeley1, Devendra K Agrawal1.   

Abstract

INTRODUCTION: Wear debris-induced osteolysis is a common cause of arthroplasty failure in several joints including the knee, hip and intervertebral disc. Debris from the prosthesis can trigger an inflammatory response that leads to aseptic loosening and prosthesis failure. In the spine, periprosthetic pain also occurs following accumulation of wear debris through neovascularization of the disc. The role of the immune system in the pathobiology of periprosthetic osteolysis of joint replacements is debatable. Areas covered: We discussed the stimulation of pro-inflammatory and pro-protective and pro-regenerative pathways due to debris from the prosthetics. The balance between the two pathways may determine the outcome results. Also, the role of cytokines and immune cells in periprosthetic inflammation in the etiology of osteolysis is critically reviewed. Expert commentary: Therapies targeting the inflammatory process associated with ultra-high-molecular-weight polyethylene wear debris could reduce implant failure. Additionally, therapies targeting neovascularization of discs following arthroplasty could mitigate periprosthetic pain.

Entities:  

Keywords:  Discogenic pain; Immunopathogenesis; Inflammation; Macrophages; Osteolysis; Periprosthesis; total disc replacement

Mesh:

Substances:

Year:  2018        PMID: 30099915      PMCID: PMC6287907          DOI: 10.1080/1744666X.2018.1511428

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  81 in total

1.  BMP-7 ameliorates cobalt alloy particle-induced inflammation by suppressing Th17 responses.

Authors:  Fengrong Chen; Ruisong Chen; Haoyuan Liu; Rupeng Sun; Jianming Huang; Zheyuan Huang; Guojian Jian
Journal:  APMIS       Date:  2017-07-24       Impact factor: 3.205

2.  IL-1 mediates TNF-induced osteoclastogenesis.

Authors:  Shi Wei; Hideki Kitaura; Ping Zhou; F Patrick Ross; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

3.  NF-κB decoy oligodeoxynucleotide inhibits wear particle-induced inflammation in a murine calvarial model.

Authors:  Taishi Sato; Jukka Pajarinen; Tzu-hua Lin; Yasunobu Tamaki; Florence Loi; Kensuke Egashira; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2015-07-14       Impact factor: 4.396

4.  Mutant MCP-1 protein delivery from layer-by-layer coatings on orthopedic implants to modulate inflammatory response.

Authors:  Michael Keeney; Heather Waters; Katherine Barcay; Xinyi Jiang; Zhenyu Yao; Jukka Pajarinen; Kensuke Egashira; Stuart B Goodman; Fan Yang
Journal:  Biomaterials       Date:  2013-09-26       Impact factor: 12.479

5.  Use of volumetric computerized tomography as a primary outcome measure to evaluate drug efficacy in the prevention of peri-prosthetic osteolysis: a 1-year clinical pilot of etanercept vs. placebo.

Authors:  Edward M Schwarz; Debbie Campbell; Saara Totterman; Allen Boyd; Regis J O'Keefe; R John Looney
Journal:  J Orthop Res       Date:  2003-11       Impact factor: 3.494

6.  Adenovirus-mediated small interfering RNA targeting tumor necrosis factor-α inhibits titanium particle-induced osteoclastogenesis and bone resorption.

Authors:  Haohui Guo; Jian Zhang; Shaowen Hao; Qunhua Jin
Journal:  Int J Mol Med       Date:  2013-06-11       Impact factor: 4.101

7.  Nerve growth factor expression and innervation of the painful intervertebral disc.

Authors:  A J Freemont; A Watkins; C Le Maitre; P Baird; M Jeziorska; M T N Knight; E R S Ross; J P O'Brien; J A Hoyland
Journal:  J Pathol       Date:  2002-07       Impact factor: 7.996

8.  Disrupted TH17/Treg balance in patients with chronic low back pain.

Authors:  Benjamin Luchting; Banafscheh Rachinger-Adam; Julia Zeitler; Lisa Egenberger; Patrick Möhnle; Simone Kreth; Shahnaz Christina Azad
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

9.  Total disc arthroplasty for treating lumbar degenerative disc disease.

Authors:  Keyvan Mostofi
Journal:  Asian Spine J       Date:  2015-02-13

10.  Lumbar degenerative disc disease: current and future concepts of diagnosis and management.

Authors:  Fadi Taher; David Essig; Darren R Lebl; Alexander P Hughes; Andrew A Sama; Frank P Cammisa; Federico P Girardi
Journal:  Adv Orthop       Date:  2012-04-02
View more
  6 in total

Review 1.  Artificial disc replacement in spine surgery.

Authors:  Yahya A Othman; Ravi Verma; Sheeraz A Qureshi
Journal:  Ann Transl Med       Date:  2019-09

2.  ICR in human cadaveric specimens: An essential parameter to consider in a new lumbar disc prosthesis design.

Authors:  Amparo Vanaclocha-Saiz; Carlos M Atienza; Vicente Vanaclocha; Vicente Belloch; Juan Manuel Santabarbara; Pablo Jordá-Gómez; Leyre Vanaclocha
Journal:  N Am Spine Soc J       Date:  2020-07-20

3.  MiR-92a/KLF4/p110δ regulates titanium particles-induced macrophages inflammation and osteolysis.

Authors:  Zhenkang Wen; Sipeng Lin; Changchuan Li; Zhuji Ouyang; Zhong Chen; Shixun Li; Yuxi Huang; Wenqiang Luo; Zhongcan Zheng; Peidong Guo; Manyuan Kuang; Yue Ding
Journal:  Cell Death Discov       Date:  2022-04-13

Review 4.  New Hope for Treating Intervertebral Disc Degeneration: Microsphere-Based Delivery System.

Authors:  Taowen Guo; Xiaobo Zhang; Yicun Hu; Maoqiang Lin; Ruihao Zhang; Xiangyi Chen; Dechen Yu; Xin Yao; Peng Wang; Haiyu Zhou
Journal:  Front Bioeng Biotechnol       Date:  2022-07-19

5.  Bionate Biocompatibility: In Vivo Study in Rabbits.

Authors:  Amparo Vanaclocha-Saiz; Vicente Vanaclocha; Carlos Atienza; Pablo Jorda-Gomez; Víctor Primo-Capella; Carlos Barrios; Leyre Vanaclocha
Journal:  ACS Omega       Date:  2022-08-19

Review 6.  Biomaterials-Driven Sterile Inflammation.

Authors:  Henry Chen; Devendra K Agrawal; Finosh G Thankam
Journal:  Tissue Eng Part B Rev       Date:  2021-02-23       Impact factor: 6.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.